Molecular detection of multiple (viral and bacterial) pathogens in clinical and environmental samples
Contact person details
Name: / FAIRLEY , Derek ( Dr)
Position: / Research Scientist
Name of Organisation: / Regional Virus Laboratory, Royal Hospitals Trust
URL:
E-mail: / Contact
Telephone: / +44-2890-635303
Fax number:
Collaboration
Type: Company Expertise
Title: Molecular detection of multiple (viral and bacterial) pathogens in clinical and environmental samples
Participation: Type A
Type Details: The Regional Virus Laboratory (RVL) is based at the Royal Victoria Hospital, and provides a comprehensive regional service for detection and diagnosis of viral infections (and certain bacterial infections) for all hospitals and general practitioners in Northern Ireland.
The laboratory currently processes requests from over 1600 individual users (hospital consultants and general practitioners) and from all health service trusts in Northern Ireland. A broad range of diagnostic tests are in use, and over 40,000 molecular assays (for pathogen detection) and 80,000 serological assays (for pathogen detection or patient immunity) are completed annually.
In addition, the RVL provides sequence-based viral genotyping services and a public health virology service for the investigation of outbreaks of infectious disease. It is part of the European Influenza Surveillance Scheme (EISS), and is a designated WHO influenza laboratory for diagnosis and research. The laboratory also maintains a unique epidemiological database of all diagnosed viral and atypical bacterial infections in Northern Ireland.
The RVL has been at the forefront of developing and clinically validating new molecular diagnostic tests, and bringing these tests into routine use. The laboratory was the first regional service in the UK to switch completely from traditional tissue culture to using PCR and real-time PCR methods for diagnosis of respiratory viral infections. As well as new PCR-based molecular assays, the RVL is also developing novel microarray-based multipathogen assays, bacterial and viral T-RFLP and fragment analysis methods, MALDI-TOF nucleic acid mass spectrometry methods and rapid isothermal amplification assays for point-of-care use - along with bioinformatics infrastructure to support these new methods.
Programme: FP7 , FP7-KBBE , FP7-HEALTH
Instruments: CP Collaborative project (generic),CSA Coordination and support actions,CP-FP Small or medium-scale focused research project,CP-IP Large-scale integrating project,CP-TP Collaborative Project targeted to a special group (such as SMEs),CP-SICA Collaborative project for specific cooperation actions dedicated to international cooperation partner countries (SICA)
Research interest:
Expiry Date: 2009-01-13
Workprogramme area(s)/key action(s):
Target Partner
Expertise:
We would particularly like to make contacts with academic or SME partners who have expertise in any of the following areas:
- diagnostic instrument platforms
- laboratory automation and liquid handling
- high-throughput screening methods
- microfluidics and lab-on-chip technology
- point-of-care and near-patient testing
- patient genotyping
Country: Österreich, Belgique-België, Schweiz/Suisse/Svizzera, Ceska Republika, Deutschland, Danmark, Eesti, España, Suomi/Finland, France, Hellas, Magyarorszag, Éire/Ireland, Ísland, Italia, Lietuva, Luxembourg (Grand-Duché), Latvija, Malta, Nederland, Polska, Portugal, Sverige, Slovenija, Slovenska Republika
Organization Details
Name: / Regional Virus Laboratory, Royal Hospitals Trust
Department: / Regional Virology Laboratory, Microbiology Department
Address: / Belfast
UNITED KINGDOM
Type: / Research, Other
Number of Employees: / > 500
Details:
SIC Codes: / Biotechnology , Life Sciences , Medical biotechnology , Medicine, Health , Scientific Research
Keywords: / pathogen
viral
bacterial
molecular
diagnostic
PCR
microarray
clinical
microbiology
infection
Partners already acquired:
Record control number: 74706
Quality validation date: 2008-01-14
CORDIS RTD-Partners / © European Communities.